129 related articles for article (PubMed ID: 8102134)
1. Utilization of peripheral blood stem cells in autotransplantation.
Kessinger A
Hematol Oncol Clin North Am; 1993 Jun; 7(3):535-45. PubMed ID: 8102134
[TBL] [Abstract][Full Text] [Related]
2. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
3. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
[TBL] [Abstract][Full Text] [Related]
4. Is blood or bone marrow better?
Kessinger A
Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
[TBL] [Abstract][Full Text] [Related]
5. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood and bone marrow hematopoietic stem cells: are they the same?
Janssen WE
Semin Oncol; 1993 Oct; 20(5 Suppl 6):19-27. PubMed ID: 8211212
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
8. [Economic costs of autotransplantation of hematopoietic progenitors].
de Arriba F; Heras I; del Carmen Garcia M; Moraleda JM; Funes C; Ferrer F; Vicente V
Med Clin (Barc); 1996 Mar; 106(9):329-32. PubMed ID: 8667698
[TBL] [Abstract][Full Text] [Related]
9. The use of peripheral stem cell support of high-dose chemotherapy.
Kessinger A; Armitage JO
Important Adv Oncol; 1993; ():167-75. PubMed ID: 8099339
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
12. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
13. The use of autologous transplantation in the treatment of malignant disorders.
Territo M
J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
[TBL] [Abstract][Full Text] [Related]
14. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
15. Techniques of harvesting and cryopreservation of stem cells.
Meagher RC; Herzig RH
Hematol Oncol Clin North Am; 1993 Jun; 7(3):501-33. PubMed ID: 8102133
[TBL] [Abstract][Full Text] [Related]
16. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
17. Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Vose JM; Armitage JO
Hematol Oncol Clin North Am; 1993 Jun; 7(3):577-90. PubMed ID: 8102135
[TBL] [Abstract][Full Text] [Related]
18. The Nebraska experience.
Kessinger A
Stem Cells; 1995 Dec; 13 Suppl 3():23-7. PubMed ID: 8747985
[TBL] [Abstract][Full Text] [Related]
19. New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients.
Bruserud O; Tjønnfjord G; Gjertsen BT; Foss B; Ernst P
Stem Cells; 2000; 18(5):343-51. PubMed ID: 11007918
[TBL] [Abstract][Full Text] [Related]
20. Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients.
Holowiecki J; Grosicki S; Sadus-Wojciechowska M; Kachel L; Hellmann A; Mital A; Skotnicki AB; Piatkowska-Jakubas B; Jedrzejczak WW; Paluszewska M; Wach M; Marianska B; Wrzesien-Kus A; Krawczyk-Kulis M; Wojnar J
Transplant Proc; 2005 Dec; 37(10):4482-7. PubMed ID: 16387150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
